Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy

Table 2 Log-rank test of Maspin expression with MIBC survival time

Log rank (Mantel-Cox)	χ ²	95 % CI	P value
Maspin and OS	8.49	1.521–8.515	0.0036
Maspin and PFS	12.17	1.725–6.980	0.0005

OS overall survival, PFS progression-free survival, CI confidence interval. P < 0.05 was considered statistically significant

ISSN: 1756-9966